Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Ocumetics Technology Corp.

OTCFFPNK
Healthcare
Medical - Instruments & Supplies
$0.30
$-0.01(-4.07%)
U.S. Market opens in 1h 34m

Ocumetics Technology Corp. Fundamental Analysis

Ocumetics Technology Corp. (OTCFF) shows weak financial fundamentals with a PE ratio of -13.06, profit margin of 0.00%, and ROE of 1.24%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

PEG Ratio-0.54

Areas of Concern

ROE1.24%
Operating Margin0.00%
Cash Position2.42%
Current Ratio0.19
We analyze OTCFF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 53.2/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
53.2/100

We analyze OTCFF's fundamental strength across five key dimensions:

Efficiency Score

Weak

OTCFF struggles to generate sufficient returns from assets.

ROA > 10%
-2.41%

Valuation Score

Excellent

OTCFF trades at attractive valuation levels.

PE < 25
-13.06
PEG Ratio < 2
-0.54

Growth Score

Moderate

OTCFF shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
20.25%

Financial Health Score

Moderate

OTCFF shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.19

Profitability Score

Weak

OTCFF struggles to sustain strong margins.

ROE > 15%
124.17%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is OTCFF Expensive or Cheap?

P/E Ratio

OTCFF trades at -13.06 times earnings. This suggests potential undervaluation.

-13.06

PEG Ratio

When adjusting for growth, OTCFF's PEG of -0.54 indicates potential undervaluation.

-0.54

Price to Book

The market values Ocumetics Technology Corp. at -12.87 times its book value. This may indicate undervaluation.

-12.87

EV/EBITDA

Enterprise value stands at -6.61 times EBITDA. This is generally considered low.

-6.61

How Well Does OTCFF Make Money?

Net Profit Margin

For every $100 in sales, Ocumetics Technology Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $1.24 in profit for every $100 of shareholder equity.

1.24%

ROA

Ocumetics Technology Corp. generates $-2.41 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.41%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

OTCFF converts -11.74% of its market value into free cash.

-11.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-13.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.54

vs 25 benchmark

P/B Ratio

Price to book value ratio

-12.87

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.19

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.24

vs 25 benchmark

ROA

Return on assets percentage

-2.41

vs 25 benchmark

ROCE

Return on capital employed

1.21

vs 25 benchmark

How OTCFF Stacks Against Its Sector Peers

MetricOTCFF ValueSector AveragePerformance
P/E Ratio-13.0628.25 Better (Cheaper)
ROE124.17%780.00% Weak
Net Margin0.00%-20122.00% (disorted) Weak
Debt/Equity-1.230.30 Strong (Low Leverage)
Current Ratio0.194.66 Weak Liquidity
ROA-241.05%-14687.00% (disorted) Weak

OTCFF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ocumetics Technology Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-111.94%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-54.05%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ